Loading...
XTAE
ERKA
Market cap5mUSD
Oct 12, Last price  
16.80ILS
Name

Erika B-Cure Laser Ltd

Chart & Performance

D1W1MN
XTAE:ERKA chart
P/E
P/S
0.46
EPS
Div Yield, %
Shrs. gr., 5y
0.12%
Rev. gr., 5y
-5.67%
Revenues
38m
+27.03%
35,518,00050,834,00085,772,000105,515,00049,496,00029,883,00037,961,000
Net income
-9m
L-50.73%
2,537,0002,343,00012,463,000-9,692,000-44,016,000-19,221,000-9,470,000
CFO
-4m
L-52.91%
5,264,0005,648,00018,206,000-28,749,000-33,798,000-8,973,000-4,225,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Erika B-Cure Laser Ltd, established in Haifa, Israel in 2007, is a company dedicated to the full lifecycle of its B-Cure laser product line, from development and manufacturing to global marketing, sales, and distribution. Formerly known as Erica Carmel Ltd until its rebranding in January 2022, the company offers a diverse array of laser devices tailored for various therapeutic applications in both domestic and international markets. Their product portfolio includes: The B-Cure Laser Classic, a medical device for home use that addresses a broad spectrum of conditions including general pain, orthopedic issues, dermatological problems, inflammation, and supports wound healing. The B-Cure Laser Pro, designed to treat more severe or chronic ailments such as persistent orthopedic challenges, diabetic wounds, and difficulties in recovery, including mucositis. The B-Cure Laser Sport, a home-based device for managing sports injuries, athletic discomfort, and other orthopedic concerns. The professional-grade B-Cure Laser Sport Pro, which provides advanced treatment for sports-related injuries, pain relief in muscles and various body areas, and helps combat infections like Achilles tendonitis. For dental professionals, the B-Cure Laser Dental is an in-clinic device formulated to tackle a variety of oral health problems, alleviate gum pain and inflammation, expedite recovery post-dental procedures (including implants), and reduce associated swelling and discomfort. Additionally, the B-Pro Dental Laser Cure is available for dental clinics, specifically engineered to address diverse dental issues and infections.
IPO date
Aug 01, 2021
Employees
58
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT